Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/9/14 → 02/24/18 |
Funding
- National Cancer Institute: $2,350.00
Alliance: Phase III Trial of Enzalutamide (NSC#766085) versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
- Wu, Shenhong (PI)
- Keresztes, Roger (CoPI)
- Kudelka, Andrzej (CoPI)
Project: Research